BC Cancer Foundation - Spring 2015 - (Page 8)
The Future of
Prostate
Cancer Care
ART
new head
The Future of Prostate
Cancer Care
How Dr. Kim Chi translates research into care
F
Dr. Kim Chi
8
PARTNeRS IN DISCOVeRY
or Dr. Kim Chi, "multi-tasking"
is a familiar term.
As a medical oncologist at
the BC Cancer Agency, Dr. Chi
treats patients with genitourinary (GU)
cancers, which includes the prostate,
bladder, testis, kidney and adrenal
gland. He is a leading expert in prostate cancer research, which means he
devotes part of his workweek to studying cancer outcomes and biomarkers and conducting clinical trials.
Throughout his 15-year career
at the BC Cancer Agency
and the Vancouver Prostate
Centre, Dr. Chi has received
international recognition
for his contributions to
this field.
When he is not busy
in the lab or the clinic,
Dr. Chi teaches medical
students, residents and
fellows, and chairs the
Agency's GU Tumour
Group, a multidisciplinary group of doctors,
pharmacists and other
health professionals
responsible for defining
treatment guidelines and
policies for treating GU
cancers across the province.
Dr. Chi also believes
strongly in collaboration and
works with several national and
international groups to conduct
clinical trials across Canada and
around the world. "Cancer is a huge
problem," he says, "but at the same
time there are a lot of good ideas to
work on and no one facility can do
everything. It's very important for us
to collaborate with other groups to
test the best ideas faster."
Even with his hectic schedule,
Dr. Chi's motivation to continue this
important work is strong: "What
attracted me first and foremost to a
career in oncology was the interaction
with patients and their families. Being
able to help someone make the best
choices for themselves and deal with
all the outcomes is very rewarding,"
says Dr. Chi.
THE CLINICIAN
RESEARCHER AWARD
Though accustomed to fitting research
time around his many other professional duties, Dr. Chi wished for more
hours to focus exclusively on "translating discoveries into treatments
that benefit people in the clinic and
understand what makes prostate
cancers sensitive or resistant to certain treatments."
In 2013, a generous pledge of
$1.5 million from the Tait family put
Dr. Chi's wish within reach when the
BC Cancer Foundation established
the first-ever peer-reviewed Clinician
Researcher Awards. The goal of the
competition was to provide additional
Table of Contents for the Digital Edition of BC Cancer Foundation - Spring 2015
Contents
Opening Thoughts
Healthy Insights
Why I Give
Researcher Profile
The Future of Prostate Cancer Care
Game-Changing Cancer Research
The Protein Link to Cancer
Legacy Giving
Regional Roundup
BC Cancer Foundation - Spring 2015
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2018spring
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017winter
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017fall
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017donorreport
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017spring
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2016winter
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2016fall
https://www.nxtbook.com/nxtbooks/manifest/bccancer_impactreport2016
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2016spring
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015winter
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015fall
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015report
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015spring
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014winter
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014fall
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014report
https://www.nxtbookmedia.com